Overview

Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults

Status:
Recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of multiple-dose subcutaneous injections of Genakumab for Injection in Chinese healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
GeneScience Pharmaceuticals Co., Ltd.
Collaborator:
Affiliated Hospital of North Sichuan Medical College